Science
My Strategy to Buy Beam Therapeutics
Let's look at the charts and indicators.
Illumina Gets a Fundamental Bump
Here's where aggressive traders could look to probe the long side of ILMN.
For DOCS, the Writing Is on the Wall
Doximity has not finished its decline, according to the charts.
Here's Where DexCom Could Rally
Let's look at the charts and indicators.
United Therapeutics May Need to Take a Breather From the Rally
Let's look at the charts of the biotech.
Does Halozyme Therapeutics, My Q2 Pick, Still Have a HALO Over It?
Let's check the charts on this biotechnology stock and see if it still has a prayer.
We Have a New AbbVie Price Target After Our Previous One Was Reached
Here's our fresh take on the shares.
Is This Pullback in Knowles Corp a Buying Opportunity?
Patient investors could go long KN at current levels.
Beaten-Down Biogen Could Finally Be Reaching an 'Interesting' Level
The shares have been cut in half over the last six months.
'A' Is for Buying: Agilent Is Resuming Its Uptrend
Here's how traders can play the stock.